# Finance of America Companies Inc.: financial statements, quarterly

FOA · NYSE · CIK 1828937 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/foa.md) · [Financials](/companies/foa/financials.md) · [Filings](/companies/foa/filings.md) · [Insiders](/companies/foa/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/foa/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [(70.4)](/filings/0001828937-25-000044.md) | [276 d](/filings/0001828937-25-000032.md) | [74.7](/filings/0001828937-25-000033.md) | [79.0](/filings/0001828937-25-000061.md) | [290](/filings/0001628280-25-052025.md) | [(49.4) d](/filings/0001628280-26-017692.md) | [166](/filings/0001628280-26-033536.md) | [177](/filings/0001628280-26-054843.md) | [80.8](/filings/0001628280-25-052025.md) | [73.5 d](/filings/0001628280-26-017692.md) | [120](/filings/0001628280-26-033536.md) | [62.5](/filings/0001628280-26-054843.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [28.0](/filings/0001828937-23-000118.md) | [27.5 d](/filings/0001828937-24-000024.md) | [28.5](/filings/0001828937-24-000039.md) | [9.3](/filings/0001828937-25-000061.md) | [9.2](/filings/0001628280-25-052025.md) | [(43.3) d](/filings/0001628280-26-017692.md) | [14.9](/filings/0001828937-25-000033.md) | [15.2](/filings/0001828937-25-000061.md) | [14.5](/filings/0001628280-25-052025.md) | [12.9 d](/filings/0001628280-26-017692.md) | not reported | not reported |
| Income tax | $m | [(0.1)](/filings/0001828937-25-000044.md) | [0.2 d](/filings/0001828937-25-000032.md) | [0.0](/filings/0001828937-25-000033.md) | [1.2](/filings/0001828937-25-000061.md) | [4.4](/filings/0001628280-25-052025.md) | [(3.2) d](/filings/0001628280-26-017692.md) | [1.9](/filings/0001628280-26-033536.md) | [2.1](/filings/0001628280-26-054843.md) | [0.1](/filings/0001628280-25-052025.md) | [(0.7) d](/filings/0001628280-26-017692.md) | [1.1](/filings/0001628280-26-033536.md) | [(42.2)](/filings/0001628280-26-054843.md) |
| Net income | $m | [(65.4)](/filings/0001828937-25-000044.md) | [61.4 d](/filings/0001828937-25-000032.md) | [(7.5)](/filings/0001828937-25-000033.md) | [(2.1)](/filings/0001828937-25-000061.md) | [84.2](/filings/0001628280-25-052025.md) | [(59.1) d](/filings/0001628280-26-017692.md) | [30.2](/filings/0001628280-26-033536.md) | [34.9](/filings/0001628280-26-054843.md) | [(9.5)](/filings/0001628280-25-052025.md) | [(10.4) d](/filings/0001628280-26-017692.md) | [17.5](/filings/0001628280-26-033536.md) | [2.1](/filings/0001628280-26-054843.md) |
| Diluted EPS | $ per share | [(7.45)](/filings/0001828937-25-000044.md) | not reported | [(0.78)](/filings/0001828937-25-000033.md) | [(0.30)](/filings/0001828937-25-000061.md) | [7.50](/filings/0001628280-25-052025.md) | not reported | [2.43](/filings/0001628280-26-033536.md) | [2.13](/filings/0001628280-26-054843.md) | [(1.27)](/filings/0001628280-25-052025.md) | not reported | [0.88](/filings/0001628280-26-033536.md) | [(1.28)](/filings/0001628280-26-054843.md) |
| Basic EPS | $ per share | [(7.45)](/filings/0001828937-25-000044.md) | not reported | [(0.78)](/filings/0001828937-25-000033.md) | [(0.21)](/filings/0001828937-25-000061.md) | [8.48](/filings/0001628280-25-052025.md) | not reported | [2.97](/filings/0001628280-26-033536.md) | [3.16](/filings/0001628280-26-054843.md) | [(1.05)](/filings/0001628280-25-052025.md) | not reported | [1.93](/filings/0001628280-26-033536.md) | [0.10](/filings/0001628280-26-054843.md) |

- Revenue: us-gaap:Revenues
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.1](/filings/0001828937-25-000044.md) | [0.0](/filings/0001828937-25-000044.md) | [0.0](/filings/0001828937-25-000033.md) | [0.0](/filings/0001828937-25-000061.md) | [0.0](/filings/0001628280-25-052025.md) | [0.0](/filings/0001628280-26-017692.md) | [0.1](/filings/0001628280-26-033536.md) | [0.0](/filings/0001628280-26-054843.md) | [0.1](/filings/0001628280-25-052025.md) | [0.1](/filings/0001628280-26-054843.md) | [0.1](/filings/0001628280-26-033536.md) | [0.1](/filings/0001628280-26-054843.md) |
| Current assets | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [26.4](/filings/0001828937-23-000118.md) | [27.1](/filings/0001828937-25-000044.md) | [27.7](/filings/0001828937-24-000039.md) | [28.0](/filings/0001828937-25-000042.md) | [29.0](/filings/0001828937-25-000044.md) | [29.2](/filings/0001628280-26-017692.md) | [29.7](/filings/0001828937-25-000033.md) | [30.1](/filings/0001828937-25-000061.md) | [30.7](/filings/0001628280-25-052025.md) | [30.7](/filings/0001628280-26-054843.md) | [31.3](/filings/0001628280-26-033536.md) | [37.3](/filings/0001628280-26-054843.md) |
| Current liabilities | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $bn | [26.3](/filings/0001828937-23-000118.md) | [26.8](/filings/0001828937-25-000044.md) | [27.4](/filings/0001828937-24-000039.md) | [27.7](/filings/0001828937-25-000042.md) | [28.5](/filings/0001828937-25-000044.md) | [28.8](/filings/0001628280-26-017692.md) | [29.3](/filings/0001828937-25-000033.md) | [29.7](/filings/0001828937-25-000061.md) | [30.3](/filings/0001628280-25-052025.md) | [30.3](/filings/0001628280-26-054843.md) | [30.9](/filings/0001628280-26-033536.md) | [36.9](/filings/0001628280-26-054843.md) |
| Long-term debt | $bn | not reported | [0.4](/filings/0001828937-25-000032.md) | not reported | not reported | not reported | [0.4](/filings/0001828937-25-000032.md) | not reported | not reported | [0.4](/filings/0001628280-25-052025.md) | [0.4](/filings/0001628280-26-017692.md) | not reported | not reported |
| Shareholders' equity | $bn | [0.1](/filings/0001828937-25-000044.md) | [0.3](/filings/0001628280-26-017692.md) | [0.3](/filings/0001828937-25-000061.md) | [0.3](/filings/0001628280-25-052025.md) | [0.5](/filings/0001628280-25-052025.md) | [0.3](/filings/0001628280-26-054843.md) | [0.4](/filings/0001628280-26-054843.md) | [0.5](/filings/0001628280-26-054843.md) | [0.4](/filings/0001628280-25-052025.md) | [0.4](/filings/0001628280-26-054843.md) | [0.4](/filings/0001628280-26-054843.md) | [0.4](/filings/0001628280-26-054843.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: not reported
- Total assets: us-gaap:Assets
- Current liabilities: not reported
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(126) d](/filings/0001828937-25-000044.md) | [(61.3) d](/filings/0001828937-25-000032.md) | [(132)](/filings/0001828937-25-000033.md) | [(104) d](/filings/0001828937-25-000061.md) | [(81.4) d](/filings/0001628280-25-052025.md) | [(106) d](/filings/0001628280-26-017692.md) | [(92.1)](/filings/0001628280-26-033536.md) | [(96.5) d](/filings/0001628280-26-054843.md) | [(150) d](/filings/0001628280-25-052025.md) | [(91.4) d](/filings/0001628280-26-017692.md) | [(131)](/filings/0001628280-26-033536.md) | [(183) d](/filings/0001628280-26-054843.md) |
| Capital expenditure | $m | not reported | not reported | [0.5](/filings/0001828937-24-000039.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [188](/filings/0001828937-23-000118.md) | [190](/filings/0001828937-24-000039.md) | [8.7](/filings/0001828937-25-000042.md) | [8.8](/filings/0001828937-25-000044.md) | [9.6](/filings/0001828937-25-000033.md) | [23.1](/filings/0001828937-25-000061.md) | [23.2](/filings/0001628280-25-052025.md) | [30.2](/filings/0001628280-26-033536.md) | [30.1](/filings/0001628280-26-054843.md) | [19.2](/filings/0001628280-25-052025.md) | [19.2](/filings/0001628280-26-033536.md) | [17.0](/filings/0001628280-26-054843.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 62,642,931 at 2022-08-05, from the cover of the [10-Q filed 2022-08-09](/filings/0001193125-22-216269.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.